Publication | Closed Access

Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group

MedicineCancer ManagementSouthwest Oncology GroupGynecologyRefractory Endometrial AdenocarcinomaPhase Ii StudyMolecular OncologyCancer TreatmentOncologyRadiation OncologyGynecology OncologyCancer ResearchEndocrine-related Cancer